| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.964 | 61.911 | 50.319 | 31.769 | 26.743 | 20.451 | 20.518 | 21.733 | 20.329 | 20.851 |
| Total Income - EUR | 29.014 | 64.416 | 52.893 | 31.770 | 37.531 | 21.822 | 22.601 | 23.059 | 20.407 | 20.851 |
| Total Expenses - EUR | 19.161 | 17.600 | 16.622 | 14.191 | 29.236 | 17.517 | 19.674 | 19.729 | 19.053 | 23.591 |
| Gross Profit/Loss - EUR | 9.853 | 46.816 | 36.272 | 17.579 | 8.295 | 4.305 | 2.928 | 3.330 | 1.354 | -2.741 |
| Net Profit/Loss - EUR | 8.982 | 44.883 | 34.685 | 16.626 | 7.169 | 3.697 | 2.250 | 2.638 | 266 | -2.741 |
| Employees | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Reumatologie Dr.mirea Gavrila S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.867 | 20.606 | 16.317 | 12.149 | 43.236 | 31.587 | 20.297 | 9.737 | 5.023 | 3.497 |
| Current Assets | 73.780 | 120.035 | 157.902 | 175.198 | 148.125 | 159.903 | 169.940 | 13.295 | 20.189 | 14.744 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.721 | 1.434 | 1.027 | 1.720 | 1.826 | 3.048 | 1.576 | 1.989 | 1.512 | 1.767 |
| Cash | 72.059 | 118.601 | 156.874 | 173.478 | 146.299 | 156.855 | 168.364 | 11.305 | 18.676 | 12.977 |
| Shareholders Funds | 77.415 | 121.509 | 154.137 | 167.935 | 171.852 | 172.291 | 170.720 | 3.554 | 3.809 | 1.047 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.232 | 19.132 | 20.081 | 19.412 | 19.510 | 19.198 | 19.517 | 19.478 | 21.402 | 17.194 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Reumatologie Dr.mirea Gavrila S.r.l.